The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1420
ISSUE1420
July 8, 2013
Kcentra: A 4-Factor Prothrombin Complex Concentrate for Reversal of Warfarin Anticoagulation
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Kcentra: A 4-Factor Prothrombin Complex Concentrate for Reversal of Warfarin Anticoagulation
July 8, 2013 (Issue: 1420)
The FDA has approved use of Kcentra (CSL Behring), a
human-derived 4-factor prothrombin complex concentrate
(PCC), for urgent reversal of warfarin anticoagulation
in adults with acute major bleeding. It is the only
4-factor PCC available in the...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.